IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease

References

• Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D. New insights into the pathogenesis of Behçet's disease. Autoimmun Rev. 2012;11(10):687–98.
   Google Scholar
• Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet. 2010;42(8):698–706.
   Google Scholar
• Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet. 2010;42(8):703–6.
   Google Scholar
• Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol. 2010;28:445–89.
   PubMed Web of Science ®Google Scholar
• Romagnani S. Human Th17 cells. Arthritis Res Ther. 2008; 10(2):206.
   Google Scholar
• Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383(6603):787–93.
   PubMed Web of Science ®Google Scholar
• Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6(11):1123–32.
   PubMedGoogle Scholar
• Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004;21(2):241–5.
   Google Scholar
• Zhang N, Pan HF, Ye DQ. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem. 2011;353(1–2):41–6.
   Google Scholar
• Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nature Immunol. 2010;11(1):7–13.
   Google Scholar
• Yamaguchi T, Wing JB, Sakaguchi S. Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions. Semin Immunol. 2011;23(6):424–30.
   Google Scholar
• Sakaguchi S. Naturally arising Foxp3-expressing CD25 + CD4+ regulatory T cells inimmunological tolerance to self and non-self. Nat Immunol. 2005;6(4):345–52.
   Google Scholar
• Mendoza-Pinto C, García-Carrasco M, Jiménez-Hernández M, Jiménez Hernández C, Riebeling-Navarro C, Nava Zavala A, et al. Etiopathogenesis of Behcet's disease. Autoimmun Rev. 2010; 9(4):241–5.
   PubMed Web of Science ®Google Scholar
• Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, Hamzaoui A. Expression of Th-17 and RORγt mRNA in Behçet's Disease. Med Sci Monit. 2011;17(4):CR227–234.
   Google Scholar
• Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, et al. Excessive CD4 + T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease. Clin Exp Immunol. 2012;168(1):68–74.
   Google Scholar
• Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. 2009;119(12):3573–85.
   PubMedGoogle Scholar
• Akdis M, Palomares O, van de Veen W, van Splunter M, Akdis CA. TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol. 2012;129(6):1438–49.
   Google Scholar
• Sugita S, Kawazoe Y, Imai A, Kawaguchi T, Horie S, Keino H, et al. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease. J Immunol. 2013;190(11):5799–808.
   Google Scholar
• Aktas Cetin E, Cosan F, Kucuksezer UC, Bilgic S, Cagatay Y, Gul A, Deniz G.Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis. Rheumatol Int. 2013;33(3):733–41.
   Google Scholar
• Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 1999;42(9):1967–74.
   Google Scholar
• Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum. 2004;50(7):2291–95.
   Google Scholar
• Dalghous AM, Freysdottir J, Fortune F. Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD. Scand J Rheumatol. 2006;35(6):472–75.
   Google Scholar
• Houman H, Hamzaoui A, Ben Ghorbal I, Khanfir M, Feki M, Hamzaoui K. Abnormal expression of chemokine receptors inBehçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations. J Autoimmun. 2004;23(3):267–73.
   Google Scholar
• Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci. 2008;49(7):3058–64.
   PubMed Web of Science ®Google Scholar
• Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol. 2005;139(2):371–8.
   Google Scholar
• Ferrante A, Ciccia F, Principato A, Giardina AR, Impastato R, Peralta S, Triolo G. A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease. Clin Exp Rheumatol. 2010;28(4 Suppl 60):27–30.
   Google Scholar
• Yamaguchi Y, Takahashi H, Satoh T, Okazaki Y, Mizuki N, Takahashi K, et al. Natural killer cells control a T-helper 1 response in patients with Behcet's disease. Arthritis Res Ther. 2010;12(3):R80.
   Google Scholar
• Koarada S, Haruta Y, Tada Y, Ushiyama O, Morito F, Ohta A, Nagasawa K. Increased entry of CD4 + T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease. Rheumatology (Oxford). 2004;43(7):843–51.
   Google Scholar
• Mantaş C, Direskeneli H, Ekşioglu-Demiralp E, Akoglu T. Serum levels of Th2 cytokines IL-4 and IL-10 in Behçet's disease. J Rheumatol. 1999;26(2):510–2.
   Google Scholar
• Raziuddin S, Al-Dalaan A, Bahabri S, Siraj AK, Al-Sedairy S. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol. 1998;25(2):329–33.
   Google Scholar
• Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol. 2010;11(1):7–13.
   Google Scholar
• Kim JR, Chae JN, Kim SH, Ha JS. Subpopulations of regulatory T cells in rheumatoid arthritis, systemic lupus erythematosus, and Behcet's disease. J Korean Med Sci. 2012;27(9):1009–13.
   Google Scholar
• Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D, et al. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease. J Allergy Clin Immunol. 2011;128(3):655–64.
   Google Scholar
• Nanke Y, Kotake S, Goto M, Ujihara H, Matsubara, M, Kamatani N. Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: a possible predictive marker of ocular attack. Mod Rheumatol. 2008;18(4):354–8.
   PubMed Web of Science ®Google Scholar
• Sugita S, Yamada Y, Kaneko S, Horie S, Mochizuki M. Induction of regulatory T cells by infliximab in Behcet's disease. Invest Ophthalmol Vis Sci. 2011;52(4):476–84.
   Google Scholar
• Hamzaoui K, Hamzaoui A, Houman H. CD4 + CD25+ regulatory T cells in patients with Behçet's disease. Clin Exp Rheumatol. 2006;24(5 Suppl 42):S71–8.
   Google Scholar
• Hamzaoui K, Borhani Haghighi A, Ghorbel IB, Houman H. RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease. J Neuroimmunol. 2011;233(1–2):249–53.
   Google Scholar
• Pekiner FN, Aytugar E, Demirel GY, Borahan MO. Interleukin-2, interleukin6 and T regulatory cells in peripheral blood of patients withBehçet's disese and recurrent aphthous ulcerations. J Oral Pathol Med. 2012;41(1):73–9.
   Google Scholar
• Kim J, Park JA, Lee EY, Lee YJ, Song YW, Lee EB. Imbalance of Th17 to Th1 cells in Behçet's disease. Clin Exp Rheumatol. 2010;28(4 Suppl 60):S16–9.
   Google Scholar
• Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease. Arthritis Res Ther. 2012;14(3):R99.
   Google Scholar
• Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52(1):65–70.
   Google Scholar
• Kryczek I, Bruce AT, Gudjonsson JE, Johnston A, Aphale A, Vatan L, et al. Induction of IL17 + T cell trafficking and development by IFNgamma: mechanism and pathological relevance in psoriasis. J Immunol. 2008;181(7):4733–41.
   Google Scholar
• Martin-Orozco N, Chung Y, Chang SH, Wang YH, Dong C. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol. 2009;39(1):216–24.
   Google Scholar
• Shi G, Cox CA, Vistica BP, Tan C, Wawrousek EF, Gery I. Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells. J Immunol. 2008;181(10):7205–13.
   Google Scholar
• Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol. 2009;10(8):857–63.
   PubMedGoogle Scholar
• Zenewicz LA, Flavell RA. Recent advances in IL-22 biology. Int Immunol. 2011;23(3):159–63.
   Google Scholar
• Leung JM, Davenport M, Wolff MJ, Wiens KE, Abidi WM, Poles MA, et al. IL-22-producing CD4 + cells are depleted in actively inflamed colitis tissue. Mucosal Immunol. 2013. doi:10.1038/mi.2013.31.
   Google Scholar
• Truchetet ME, Brembilla NC, Montanari E, Allanore Y, Chizzolini C.Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther. 2011;13(5):R166.
   Google Scholar
• Zhang L, Li JM, Liu XG, Ma DX, Hu NW, Li YG, et al. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol. 2011;31(4):606–14.
   Google Scholar
• Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol. 2006;290(4):G827–38.
   Google Scholar